Action Uroplasty - UPI

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Emerging Stock Report Initiates Independent Research Coverage on Uroplasty, Inc.

CALGARY, Alberta, May 10, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research...

New Publication Highlights 2-Year Durability and Effectiveness of Macroplastique(R)

MINNEAPOLIS, March 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI) highlighted results from a two-year, multicenter clinical study...

Nine Major Presentations on Uroplasty Products at Society for Urodynamics and Female Urology 2010 Annual Meeting

MINNEAPOLIS, March 2 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company developing, manufacturing and marketing...

SUmiT Trial Results Clearly Demonstrate Therapeutic Effect of Percutaneous Tibial Nerve Stimulation

MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets...

Uroplasty Reports Results For Third Quarter FY2010

- Strong Macroplastique(R) Year-over-Year U.S. Sales Growth - - Significant Publication & Presentation Schedule for Uroplasty Products...

Uroplasty to Issue Third Fiscal Quarter Results on February 1, 2010

MINNEAPOLIS, Jan. 20 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI) announced today that it will release financial results for the...

OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months

Significant symptom improvement from Uroplasty's Urgent(R) PC treatments previously demonstrated at 12 weeks continued at 12 months MINNEAPOLIS...

Urgent(R) PC and Macroplastique(R) Abstracts Accepted for Presentation at Society for Urodynamics and Female Urology 2010 Annual

MINNEAPOLIS, Nov. 17 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing...

Uroplasty Reports Results for Second Quarter FY2010

- Macroplastique(R) Year-over-Year U.S. Sales Continue Strong Growth - - SUmiT Trial Results Recommended for Publication in Journal of Urology...

Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009

MINNEAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX:UPI) announced today that it will release financial results for the second...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

UPI - Frequently Asked Questions (FAQ)

What is the current Uroplasty share price?

The current share price of Uroplasty is US$ 0,00

What is the 1 year trading range for Uroplasty share price?

Uroplasty has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CVMCel Sci Corporation New	US$ 0,388 (28,52%)	43
KNWKnow Labs Inc	US$ 2,15 (12,57%)	1,18k
OSTXOS Therapies Incorporated	US$ 1,83 (8,93%)	8,7k
NVOXDefiance Daily Target 2x Long Nvo ETF	US$ 8,87 (8,30%)	2,31k
ARMPArmata Pharmaceuticals Inc	US$ 2,04 (7,94%)	299
ATMPiPath Select MLP ETN	US$ 20,01 (-32,58%)	11
MHHMastech Digital Inc	US$ 8,81 (-9,83%)	138
MSTYYieldMax MSTR Option Income Strategy ETF	US$ 18,63 (-7,86%)	169,29k
SMCYYieldmax Smci Option Income Strategy ETF	US$ 24,03 (-7,86%)	11,99k
MPTIM tron Industries Inc	US$ 35,10 (-7,78%)	239
BILSPDR Bloomberg 1 to3 Month T Bill ETF	US$ 91,545 (0,01%)	4,85M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 5,165 (1,97%)	4,12M
SGOViShares 0 to 3 Month Treasury Bond ETF	US$ 100,465 (0,00%)	3,98M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 4,67 (-3,11%)	3,71M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 18,25 (-0,27%)	3,42M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Uroplasty Common Stock (UPI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

UPI Dernières nouvelles

Emerging Stock Report Initiates Independent Research Coverage on Uroplasty, Inc.

New Publication Highlights 2-Year Durability and Effectiveness of Macroplastique(R)

Nine Major Presentations on Uroplasty Products at Society for Urodynamics and Female Urology 2010 Annual Meeting

SUmiT Trial Results Clearly Demonstrate Therapeutic Effect of Percutaneous Tibial Nerve Stimulation

Uroplasty Reports Results For Third Quarter FY2010

Uroplasty to Issue Third Fiscal Quarter Results on February 1, 2010

OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months

Urgent(R) PC and Macroplastique(R) Abstracts Accepted for Presentation at Society for Urodynamics and Female Urology 2010 Annual

Uroplasty Reports Results for Second Quarter FY2010

Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009

UPI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Uroplasty Common Stock (UPI) Cours

Uroplasty Common Stock (UPI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

UPI Dernières nouvelles

Emerging Stock Report Initiates Independent Research Coverage on Uroplasty, Inc.

New Publication Highlights 2-Year Durability and Effectiveness of Macroplastique(R)

Nine Major Presentations on Uroplasty Products at Society for Urodynamics and Female Urology 2010 Annual Meeting

SUmiT Trial Results Clearly Demonstrate Therapeutic Effect of Percutaneous Tibial Nerve Stimulation

Uroplasty Reports Results For Third Quarter FY2010

Uroplasty to Issue Third Fiscal Quarter Results on February 1, 2010

OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months

Urgent(R) PC and Macroplastique(R) Abstracts Accepted for Presentation at Society for Urodynamics and Female Urology 2010 Annual

Uroplasty Reports Results for Second Quarter FY2010

Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009

UPI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE